C

Cryo-Cell International
D

CCEL

7.71000
USD
-0.28
(-3.50%)
Market Closed
Volume
118
EPS
0
Div Yield
6.49
P/E
-7
Market Cap
62,159,246
Related Instruments
    B
    BLDP
    -0.06500
    (-4.42%)
    1.40500 USD
    E
    ENPH
    -1.300
    (-1.97%)
    64.840 USD
    F
    FCEL
    -0.47500
    (-6.29%)
    7.07500 USD
    N
    NKLA
    -0.05810
    (-13.20%)
    0.38200 USD
    P
    PLUG
    -0.09500
    (-5.43%)
    1.65500 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    More
News

Title: Cryo/Cell International

Sector: Healthcare
Industry: Medical Care Facilities
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.